Outlook Therapeutics Inc

NASDAQ:OTLK

8.17

-0.12 (-1.45%)

7:37:17 PM EDT: $8.00 -0.17 (-2.08%)

Outlook Therapeutics Inc Stock, NASDAQ:OTLK

485 Route 1 South, Building F, Suite 320, Iselin, New Jersey 08852

United States of America

Phone: +1.609.619.3990

Number of Employees: 24

http://www.outlooktherapeutics.com

Description

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.